CCDR: Volume 42-4, April 7, 2016: Vaccine-Preventable Diseases

Table of contents

Surveillance
Invasive bacterial diseases in Northern Canada, 2006–2013
Li YA, Martin I, Tsang R, Squires SG, Demczuk W, Desai S

Evaluation
Evaluation of the enhanced Invasive Pneumococcal Disease Surveillance System (eIPDSS) pilot project
Wijayasri S, Li YA, Squires SG, Martin I, Demczuk W, Mukhi S

Outbreak report
Outbreak of Shigella sonnei in Montréal's ultra-Orthodox Jewish community, 2015
Pilon PA, Camara B, Bekal S

Recommendation
Interim recommendations for the reporting of extensively drug resistant and pan-drug resistant isolates of Enterobacteriaceae, Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia
German GJ, Jamieson FB, Gilmour M, Almohri H, Bullard J, Domingo MC, Fuller J, Girouard G, Haldane D, Hoang L, Levett PN, Longtin J, Melano R, Needle R, Patel SN, Rebbapragada A, Reyes RC, Mulvey MR

ID News
Efficacy and safety of RTS,S/AS01 malaria vaccine
The RTS,S/AS01 vaccine continues to show modest protection
Evaluation of anthrax vaccine safety in 18-20 year olds
Single dose tetravalent dengue vaccine

Upcoming
April 18–20, 2016. 19th Annual Conference on Vaccine Research. Baltimore, MD, USA.
June 13–16, 2016. Public Health 2016. Canadian Public Health Association. Toronto, ON.
July 18–22, 2016. 21st International AIDS Conference (AIDS 2016). Durban, South Africa.

Search CCDR